SG11201703065RA - Biomarkers and methods of prediction - Google Patents

Biomarkers and methods of prediction

Info

Publication number
SG11201703065RA
SG11201703065RA SG11201703065RA SG11201703065RA SG11201703065RA SG 11201703065R A SG11201703065R A SG 11201703065RA SG 11201703065R A SG11201703065R A SG 11201703065RA SG 11201703065R A SG11201703065R A SG 11201703065RA SG 11201703065R A SG11201703065R A SG 11201703065RA
Authority
SG
Singapore
Prior art keywords
biomarkers
prediction
methods
Prior art date
Application number
SG11201703065RA
Inventor
Thomas Dieterle
Eric J Niesor
Rosemarie Kientsch-Engel
Horst Klima
Fabian Model
Gabriela Bucklar
Vinzent Rolny
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG11201703065RA publication Critical patent/SG11201703065RA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • G01N33/6815Assays for specific amino acids containing sulfur, e.g. cysteine, cystine, methionine, homocysteine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4737C-reactive protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/324Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
SG11201703065RA 2014-10-22 2015-10-20 Biomarkers and methods of prediction SG11201703065RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14189840 2014-10-22
PCT/EP2015/074242 WO2016062709A1 (en) 2014-10-22 2015-10-20 Biomarkers and methods of prediction

Publications (1)

Publication Number Publication Date
SG11201703065RA true SG11201703065RA (en) 2017-05-30

Family

ID=51867999

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201703065RA SG11201703065RA (en) 2014-10-22 2015-10-20 Biomarkers and methods of prediction

Country Status (14)

Country Link
US (1) US20170322225A1 (en)
EP (1) EP3210026A1 (en)
JP (1) JP2017533428A (en)
KR (1) KR20170072215A (en)
CN (1) CN107912057A (en)
AU (1) AU2015335016A1 (en)
BR (1) BR112017008065A2 (en)
CA (1) CA2962835A1 (en)
HK (1) HK1251877A1 (en)
IL (1) IL251204A0 (en)
MX (1) MX2017005021A (en)
RU (1) RU2017117497A (en)
SG (1) SG11201703065RA (en)
WO (1) WO2016062709A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102067610B1 (en) * 2018-05-16 2020-01-17 전남대학교산학협력단 Assessment methods and diagnostic kit for predicting long-term prognosis of acute coronary syndrome
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
RU2720182C1 (en) * 2019-02-04 2020-04-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Method for prediction of hospitalization probability in patients with ischemic heart disease
KR102177280B1 (en) * 2019-05-09 2020-11-10 고려대학교 세종산학협력단 Biomarker composition for diagnosing acute myocardial infarction comprising homocysteine sulfinic acid or cysteic acid
CN111812332A (en) * 2020-06-23 2020-10-23 中国人民解放军军事科学院军事医学研究院 Biomarker for detecting plateau hypoxia and application thereof
KR102362951B1 (en) 2020-08-13 2022-02-14 연세대학교 원주산학협력단 Method of predicting short-term mortality in ischemic stroke using the ratio of procalcitonin to c-reactive protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009092381A1 (en) * 2008-01-23 2009-07-30 Herlev Hospital, Region Hovedstaden Ykl-40 as a general marker for non-specific disease
US20110070601A1 (en) * 2008-01-23 2011-03-24 Rigshospitalet Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40
CN102421358A (en) * 2009-03-10 2012-04-18 杜克大学 Predicting coronary artery disease and risk of cardiovascular events
JP5715137B2 (en) * 2009-08-31 2015-05-07 アボット・ラボラトリーズAbbott Laboratories Biomarkers and their use for prediction of major adverse cardiac events
FI20115367A0 (en) * 2011-04-15 2011-04-15 Hytest Oy A method for determining cardiovascular events using IGFBP fragments

Also Published As

Publication number Publication date
MX2017005021A (en) 2017-06-29
JP2017533428A (en) 2017-11-09
RU2017117497A (en) 2018-11-22
WO2016062709A1 (en) 2016-04-28
CA2962835A1 (en) 2016-04-28
KR20170072215A (en) 2017-06-26
CN107912057A (en) 2018-04-13
RU2017117497A3 (en) 2019-05-16
IL251204A0 (en) 2017-05-29
AU2015335016A1 (en) 2017-04-06
HK1251877A1 (en) 2019-04-26
US20170322225A1 (en) 2017-11-09
BR112017008065A2 (en) 2018-01-23
EP3210026A1 (en) 2017-08-30

Similar Documents

Publication Publication Date Title
HK1243102A1 (en) Anti-cd79b antibodies and methods of use
HRP20181359T1 (en) Anti-jagged1 antibodies and methods of use
IL251868A0 (en) Anti-tim3 antibodies and methods of use
IL251165A0 (en) Anti-il-1beta antibodies and methods of use
HK1251877A1 (en) Biomarkers and methods of prediction
GB201401603D0 (en) Biomarkers
GB201420908D0 (en) Biomarkers
HK1231555A1 (en) Biomarker and uses thereof
IL251286A0 (en) Anti-pdgf-b antibodies and methods of use
GB2529433B (en) Winch assembly and method of use
GB201718352D0 (en) Devices and methods for detection of biomarkers
GB201512602D0 (en) Method of modelling biomarkers
ZA201702212B (en) Method of improving hair volume
IL261906A (en) Biomarkers of proteopathies and uses thereof
GB201414419D0 (en) Method of testing
GB201416015D0 (en) Biomarker
PL3111151T3 (en) Method of operating an hydraulic-binder rotary-furnace
GB2522904B (en) Method of making an airdam
GB201420239D0 (en) Biomarker
GB201507707D0 (en) Components and methods for formation of components
GB201419990D0 (en) Hprseshoe and method of manufacture
GB201420399D0 (en) Lovefullness - therapeutic method of acceptance
GB201411343D0 (en) Biomarker
GB201416797D0 (en) Contianer and method of use thereof
GB201409793D0 (en) Biomarker